Cart
sales@molnova.com
threo-Guaiacylglycerol beta-coniferyl ether
CAS No. 869799-76-8
threo-Guaiacylglycerol beta-coniferyl ether( —— )
Catalog No. M31083 CAS No. 869799-76-8
Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 531 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namethreo-Guaiacylglycerol beta-coniferyl ether
-
NoteResearch use only, not for human use.
-
Brief DescriptionThreo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
-
DescriptionThreo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number869799-76-8
-
Formula Weight376.4
-
Molecular FormulaC20H24O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NP-G2-044
NP-G2-044 is an orally active fascin inhibitor, with an IC50 of ~2 μM. It blocks tumor metastasis and increases antitumor immune response.
-
Ginsenoside Rh2 (b)
Ginsenoside Rh2 is a minor stereoisomer of ginsenoside Rh2, possesses matrix metalloproteinase inhibitory.
-
L-838417
L-838417 is a GABAA receptor subtype-selective benzodiazepine site-selective ligand and GABAA receptor-positive modulator.
